Positive, rapid and sustained effects on MDD patients treated with Relmada anti-depressant
Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).
Archives for September 25, 2023
Mural Health raises $8 million in seed funding to grow platform modernizing clinical trials
Mural Health Technologies, Inc. has raised $8 million in seed funding for the growth of its Mural link platform it says is aimed at ‘modernizing the clinical trial experience for both patients and caregivers’.
Merck KGgA collaborates with Exscientia plc in deal worth up to $674M
Exscientia plc will receive an upfront cash payment of $20 million from Merck KGaA, Darmstadt, Germany, as the companies collaborate plus potential payments of up to $674 million in aggregate.